Significance of D-dimer in Assessment of Severity and Mortality of COVID-19 Patients A Tertiary Care Hospital Study

Ashwini Suruthy, Neethu Gowdru Vishwanathan, Seema Bijjaragi

Abstract

The outbreak of COVID-19 has brought public health emergency worldwide and has been the biggest challenge to date. This study aims to study the correlation between D-dimer levels with severity and mortality in COVID-19 patients. This study will help us understand the disease's progression and monitor the disease severity and mortality in Covid-19 patients. This retrospective descriptive study was conducted over four months from April 2021- to June 2021 in a tertiary care hospital in Central Karnataka. Demographic details and clinical and laboratory parameters were obtained from electronic hospital records. Inclusion criteria are Patients who were RT-PCR confirmed positive cases were only included in this study. Exclusion criteria are Patients who had cancer, hematologic malignancies, and acute coronary syndrome were all excluded. Results of the research are A total of 75 cases were evaluated and analyzed in this study. Patients were categorized based on severity as mild to moderate and severe. Out of which 50 patients had recovered from the illness, and 25 patients have succumbed to death. Our study revealed that elevated D-dimer levels were significant (p<0.02) with the outcome of the disease, and with the mean level of 929.27 in severe patients and 466.47 in mild-moderate patients, elevated D-dimer were highly significant (p<0.001) with the severity of the disease. Conclusion research detailed investigations of 75 COVID-19 patients suggests that a significant increase in D-dimer levels was associated with mortality and severity of the disease. Therefore, we strongly recommend that the D-dimer be used to screen patients with COVID-19 to evaluate the severity and predict the prognosis and mortality in hospitalized COVID-19 patients during admission and follow-up throughout hospitalization.

Keywords

COVID-19; D-dimer; prognostic marker

Full Text:

PDF

References

Bosevski M, Krstevski G, Bosevska G, et al. (2021). The role of D-dimer in relation to the clinical course of patients with COVID-19. Acta Biochim Biophys Sin (Shanghai), 53(1), 119-120.

Ghaith, M. M., Albanghali, M. A., Aldairi, A. F., Iqbal, M. S., Almaimani, R. A., Alquthami, K., … Almasmoum, H. A. (2021). Potential Predictors of Poor Prognosis among Severe COVID-19 Patients: A Single-Center Study. Canadian Journal of Infectious Diseases and Medical Microbiology, 2021. https://doi.org/10.1155/2021/6656092.

Hadid T, Kafri Z, Al-Katib A. (2021). Coagulation and anticoagulation in COVID-19. Blood Rev, 47, 100761. DOI: 10.1016/j.blre.2020.100761

Halaby R, Popma CJ, Cohen A, Chi G, Zacarkim MR, Romero G, et al. (2015). D-dimer elevation and adverse outcomes. J Thromb Thrombolysis, 39(1), 55–9. DOI: 10.1007/s11239-014-1101-6

Liu, J., Liu, Y., Xiang, P., Pu, L., Xiong, H., Li, C. & Wang, X. (2020). Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. Journal of Translational Medicine, 18(206). DOI: 10.1186/s12967-020-02374-0

Mattiuzzi C, Lippi G. (2020). Which lessons shall we learn from the 2019 novel coronavirus outbreak? Ann Transl Med, 8, 48.

Poudel A, Poudel Y, Adhikari A, Aryal BB, Dangol D, et al. (2021) D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19. Plos One, 16(8), e0256744. https://doi.org/10.1371/journal.pone.0256744

Shah S, Shah K, Patel SB, Patel FS, Osman M, Velagapudi P, Turagam MK, Lakkireddy D, Garg J. (2020). Elevated D-dimer levels are associated with increased risk of mortality in coronavirus disease 2019: A Systematic Review and Meta-Analysis. Cardiol Rev, 28(6), 295-302.

Soni M, Gopalakrishnan R, Vaishya R, Prabu P. (2020). D-dimer level is a useful predictor for mortality in patients with COVID-19: Analysis of 483 cases. Diabetes Metab Syndr Clin Res Rev, 14, 2245–2249. pmid:33395786

Valerio L, Ferrazzi P, Sacco C, Ruf W, Kucher N, Konstantinides S V., et al. (2021). Course of D-dimer and C-Reactive Protein Levels in Survivors and Nonsurvivors with COVID-19 Pneumonia: A Retrospective Analysis of 577 Patients. Thromb Haemost, 121(1), 98–101.DOI: 10.1055/s-0040-1721317

Yao Y, Cao J, Wang Q, Shi Q, Liu K, Luo Z, et al. (2020). D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. J Intensive Care, 8, 49. pmid:32665858

Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. (2020). D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost, 18, 1324–1329. pmid:32306492

Zheng J. (2020). SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat. Int J Biol Sci, 16(10), 1678-85. doi: 10.7150/ijbs.45053

Zhou F, Yu T, Du R, et al. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 395, 1054–1062

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 395, 1054–1062.

Refbacks

  • There are currently no refbacks.